Skip to main content

Research Repository

Advanced Search

All Outputs (34)

Could primary care records be used to identify women at risk of perinatal anxiety? A mixed-methods study. (2024)
Presentation / Conference
Fisher, T., Archer, C., Bailey, J., Evans, J., Kessler, D. S., Kingstone, T., …Chew-Graham, C. (2024, March). Could primary care records be used to identify women at risk of perinatal anxiety? A mixed-methods study. Presented at BJGP Research & Publishing Conference, RCGP Headquarters in London, England, UK

Perinatal anxiety (PNA) occurs throughout the antenatal period or up to 1 year after childbirth, with a prevalence of 21%. To investigate if primary care records could be used to identify women at 'higher risk' of PNA. Mixed-methods approach using qu... Read More about Could primary care records be used to identify women at risk of perinatal anxiety? A mixed-methods study..

How can we improve support for women with perinatal anxiety in primary care? A qualitative study. (2024)
Presentation / Conference
Silverwood, V., Fisher, T., Proctor, J., Kingstone, T., Turner, K., Shivji, N., & Chew-Graham, C. (2024, March). How can we improve support for women with perinatal anxiety in primary care? A qualitative study. Presented at BJGP Research and Publishing Conference, RCGP Headquarters, London

Perinatal anxiety (PNA) occurs during pregnancy and up to 12 months post-partum. PNA affects more than 21% of women and can impact adversely on mothers, children and their families. National Institute for Health and Care Excellence (NICE) guidance id... Read More about How can we improve support for women with perinatal anxiety in primary care? A qualitative study..

Supporting people in Early Intervention in Psychosis services: the role of primary care. (2024)
Presentation / Conference
Chew-Graham, C., Rickett, M., Kingstone, T., Gupta, V., Shiers, D., French, P., …Ward, J. (2024, March). Supporting people in Early Intervention in Psychosis services: the role of primary care. Presented at BJGP Research and Publishing Conference, RCGP Headquarters, London

Early Intervention in Psychosis (EIP) services offer treatment to people experiencing a first episode of psychosis. Service users may be referred from primary care and discharged directly back at the end of their time in an EIP service. To explore th... Read More about Supporting people in Early Intervention in Psychosis services: the role of primary care..

OP169 ‘It feels like the system is almost against you’: Self-management of multiple long-term conditions amongst people experiencing socioeconomic deprivation (2023)
Presentation / Conference
Woodward, A., Davies, N., Nimmons, D., Walters, K., Stevenson, F., Protheroe, J., …Armstrong, M. (2023, September). OP169 ‘It feels like the system is almost against you’: Self-management of multiple long-term conditions amongst people experiencing socioeconomic deprivation. Presented at Society for Social Medicine Annual Scientific Meeting Abstracts, Newcastle University, England, UK

Health Care Professionals’ Perspectives of Early Intervention in Psychosis Services: A Qualitative Study (2023)
Presentation / Conference
Rickett, M., Kingstone, T., Gupta, V., Shiers, D., French, P., Lennox, B., & Chew-Graham, C. (2023, July). Health Care Professionals’ Perspectives of Early Intervention in Psychosis Services: A Qualitative Study. Poster presented at RCPsych International Congress 2023, Liverpool, England, UK

Aims
An Early Intervention in Psychosis (EIP) service offers treatment in the community to people with a first episode of psychosis. EIP is meant to be given for three years; after this time, those who are well are discharged to their GP, while thos... Read More about Health Care Professionals’ Perspectives of Early Intervention in Psychosis Services: A Qualitative Study.

P108 Exploring the Treatment Burden of Disease Modifying Anti-Rheumatic Drug Monitoring in People with Rheumatoid Arthritis: A Qualitative Study with Recommendations for Practice (2023)
Presentation / Conference
Ryan, S. J., Bullock, L., Manning, F., Paskins, Z., & Chew-Graham, C. (2023, April). P108 Exploring the Treatment Burden of Disease Modifying Anti-Rheumatic Drug Monitoring in People with Rheumatoid Arthritis: A Qualitative Study with Recommendations for Practice. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

The experiences of remote consulting for people with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and fibromyalgia in primary care (2023)
Presentation / Conference
Leach, H., Atherton, H., Eccles, A., & Chew-Graham, C. (2023, March). The experiences of remote consulting for people with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and fibromyalgia in primary care. Presented at BJGP Research Conference 2023, London, England, UK

Background Restrictions due to the COVID-19 pandemic resulted in a sudden shift to a predominantly remote consulting model in primary care from March 2020. Little evidence exists examining the experience of remote consulting for people living with ch... Read More about The experiences of remote consulting for people with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and fibromyalgia in primary care.

Under Pressure - Pharmacist's perceptions of the effects of postgraduate education on their wellbeing: a qualitative study (2022)
Presentation / Conference
O'Byrne, R., White, S., & Chew-Graham, C. (2022, September). Under Pressure - Pharmacist's perceptions of the effects of postgraduate education on their wellbeing: a qualitative study. Paper presented at Pharmacy Education Conference 2022, Stopford Building, Oxford Road, The University of Manchester, UK

Background:
A 2019 NHS commission on the mental wellbeing of healthcare postgraduate learners reported research largely focused on doctors in training and identified the need for further research into the wellbeing needs and ways to support wellbein... Read More about Under Pressure - Pharmacist's perceptions of the effects of postgraduate education on their wellbeing: a qualitative study.

Does anxiety moderate the efficacy of mirtazapine in patients with treatment resistant depression? A secondary analysis of the mir trial (2020)
Presentation / Conference
Rifkin-Zybutz, R., Macneill, S., Dickens, C., Campbell, J., Chew-Graham, C., Peters, T., …Kessler, D. (2020, July). Does anxiety moderate the efficacy of mirtazapine in patients with treatment resistant depression? A secondary analysis of the mir trial. Poster presented at 28th European Congress of Psychiatry, Madrid, Spain

Introduction:
Mirtazapine has been shown to be effective in treating patients with both depression and anxiety symptoms.1 This has not been examined in primary care.

Objectives:
We examined whether anxiety moderated the effect of mirtazapine com... Read More about Does anxiety moderate the efficacy of mirtazapine in patients with treatment resistant depression? A secondary analysis of the mir trial.

EXPERIENCES OF DELIVERING A NURSE-LED FRACTURE RISK ASSESSMENT FOR PATIENTS WITH INFLAMMATORY RHEUMATOLOGICAL CONDITIONS IN PRIMARY CARE (2020)
Presentation / Conference
Hawarden, A. W., Paskins, Z., Ediriweera Desilva, E., Herron, D., Machin, A., Jinks, C., …Chew-Graham, C. (2020, April). EXPERIENCES OF DELIVERING A NURSE-LED FRACTURE RISK ASSESSMENT FOR PATIENTS WITH INFLAMMATORY RHEUMATOLOGICAL CONDITIONS IN PRIMARY CARE. Poster presented at British Society for Rheumatology Annual Conference 2020, Glasgow, Scotland, UK

Background
The INCLUDE (INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community) pilot trial aimed to evaluate the feasibility and acceptability of a nurse-delivered review in primary care for people... Read More about EXPERIENCES OF DELIVERING A NURSE-LED FRACTURE RISK ASSESSMENT FOR PATIENTS WITH INFLAMMATORY RHEUMATOLOGICAL CONDITIONS IN PRIMARY CARE.

DIabetes Severity SCOre (DISSCO) improves hospitalisation and mortality prediction: model development and validation in 139,626 people with type 2 diabetes (2019)
Presentation / Conference
Zghebi, S., Mamas, M., Ashcroft, D. M., Salisbury, C., Mallen, C., Chew-Graham, C., …Kontopantelis, E. (2019, September). DIabetes Severity SCOre (DISSCO) improves hospitalisation and mortality prediction: model development and validation in 139,626 people with type 2 diabetes. Paper presented at 55th EASD Annual Meeting of the European Association for the Study of Diabetes, Barcelona, Spain

Early signs of bipolar disorder in a UK primary care patient cohort (2019)
Presentation / Conference
Morgan, C., Ashcroft, D. M., Webb, R. T., Chew-Graham, C. A., Francis, A., & Yung, A. R. (2019, August). Early signs of bipolar disorder in a UK primary care patient cohort. Paper presented at 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Pennsylvania Convention Center, Philadelphia, PA, USA

Background: Bipolar Disorder (BD) is a serious mental illness characterized by mood instability. Delay in diagnosis is typically between 6–10 years with many experiencing persistent untreated symptoms and potentially poorer outcomes such as poor soci... Read More about Early signs of bipolar disorder in a UK primary care patient cohort.

A systematic review of measures using clinical data for assessing the severity of Type 2 diabetes (2019)
Presentation / Conference
Zghebi, S., Panagioti, M., Rutter, M., Ashcroft, D., van Marwijk, H., Salisbury, C., …Kontopantelis, E. (2019, March). A systematic review of measures using clinical data for assessing the severity of Type 2 diabetes. Poster presented at Diabetes UK Professional Conference 2019, ACC Liverpool, Liverpool, UK

Background/Aims: The assessment of disease severity in people with diabetes enables identification of patients in need for intensive and targeted therapies, and could help optimise the allocation of healthcare resources. We aimed to identify and appr... Read More about A systematic review of measures using clinical data for assessing the severity of Type 2 diabetes.

INCREASED RISK OF SELF-HARM IN PATIENTS WITH OSTEOPOROSIS: A UK POPULATION STUDY (2018)
Presentation / Conference
Prior, J., Whittle, R., Abdul-Sultan, A., Chew-Graham, C., Sumathipala, A., Sheperd, T., …Paskins, Z. (2018, December). INCREASED RISK OF SELF-HARM IN PATIENTS WITH OSTEOPOROSIS: A UK POPULATION STUDY. Poster presented at Osteoporosis Conference 2018, Birmingham, UK

Background: Prevention of self-harm, as a key risk factor for suicide, is an international public health priority. The World Health Organization recommends that clinicians should assess the potential for self-harm in patients in high-risk groups e.g.... Read More about INCREASED RISK OF SELF-HARM IN PATIENTS WITH OSTEOPOROSIS: A UK POPULATION STUDY.

Preterm delivery and maternal cardiovascular disease future risk: A systematic review and meta-analysis (2018)
Presentation / Conference
Wu, P., Gulati, M., Kwok, C., Wong, C., Narain, A., O'Brien, S., …Mamas, M. (2018, April). Preterm delivery and maternal cardiovascular disease future risk: A systematic review and meta-analysis. Poster presented at British Maternal & Fetal Medicine Society (BMFMS) 20th Annual Conference 2018, Brighton, UK

Objectives

We aimed to systematically evaluate and summarise the evidence on the relationship between preterm birth (<37 weeks of gestational age) and maternal cardiovascular diseases future risk.

Design

Systematic review and meta-analysis o...

Severity domains for quantifying the severity of Type 2 diabetes using primary care data and linked hospitalisation records from England (2018)
Presentation / Conference
ZGHEBI, S., Rutter, M., Ashcroft, D., Van Marwijk, H., Mallen, C., Chew-Graham, C. A., …Kontopantelis, E. (2018, March). Severity domains for quantifying the severity of Type 2 diabetes using primary care data and linked hospitalisation records from England. Poster presented at Diabetes UK Professional Conference 2018, London ExCeL, London, UK

Aims: Despite the increasing prevalence of Type 2 diabetes, which presents a significant burden on healthcare resources, there is no agreed validated UK measure to infer Type 2 diabetes severity from electronic health records (EHRs). This study aimed... Read More about Severity domains for quantifying the severity of Type 2 diabetes using primary care data and linked hospitalisation records from England.